检索结果 - Michael Lübbert

Refine Results
  1. 1
    CD34<sup>−</sup>Hematopoietic Stem Cells: Current Concepts and Controversies

    CD34<sup>−</sup>Hematopoietic Stem Cells: Current Concepts and Controversies 由 Yalin Guo, Michael Lübbert, Monika Engelhardt

    出版 2003
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiation

    Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiation 由 Michael Lübbert, Miller Cw, HP Koeffler

    出版 1991
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy

    Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy 由 Ludovica Morera, Michael Lübbert, Manfred Jung

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells

    Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells 由 Michael Lübbert, F. Herrmann, HP Koeffler

    出版 1991
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia

    DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukem... 由 Christian Flotho, Sebastian Sommer, Michael Lübbert

    出版 2017
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms

    AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms 由 Kai Rejeski, Jesús Duque‐Afonso, Michael Lübbert

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  7. 7
    Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives

    Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives 由 Insa Schiffmann, Gabriele Greve, Manfred Jung, Michael Lübbert

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Clinical Results of Hypomethylating Agents in AML Treatment

    Clinical Results of Hypomethylating Agents in AML Treatment 由 Marjan Cruijsen, Michael Lübbert, Pierre W. Wijermans, Gerwin Huls

    出版 2014
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  9. 9
    Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

    Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy 由 Julia M. Wagner, Björn Hackanson, Michael Lübbert, Manfred Jung

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies

    Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies 由 Julia Stomper, John Charles Rotondo, Gabriele Greve, Michael Lübbert

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  11. 11
    CXCR4 is a prognostic marker in acute myelogenous leukemia

    CXCR4 is a prognostic marker in acute myelogenous leukemia 由 Anke Spoo, Michael Lübbert, William G. Wierda, Jan A. Burger

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression.

    p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression. 由 Michael Lübbert, Carl W. Miller, L. Crawford, H. Phillip Koeffler

    出版 1988
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Clinical development of demethylating agents in hematology

    Clinical development of demethylating agents in hematology 由 Shyamala C. Navada, Juliane Steinmann, Michael Lübbert, Lewis R. Silverman

    出版 2014
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  14. 14
    Characterization of DNA Demethylation Effects Induced by 5-Aza-2′-Deoxycytidine in Patients with Myelodysplastic Syndrome

    Characterization of DNA Demethylation Effects Induced by 5-Aza-2′-Deoxycytidine in Patients with Myelodysplastic Syndrome 由 Cora Mund, Björn Hackanson, Carlo Stresemann, Michael Lübbert, Frank Lyko

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Control of tetrahydrobiopterin synthesis in T lymphocytes by synergistic action of interferon-gamma and interleukin-2.

    Control of tetrahydrobiopterin synthesis in T lymphocytes by synergistic action of interferon-gamma and interleukin-2. 由 Irmgard Ziegler, Karin Schott, Michael Lübbert, F. Herrmann, U. Schwuléra, Adelbert Bacher

    出版 1990
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells

    The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells 由 Gabriele Greve, Insa Schiffmann, Dietmar Pfeifer, Milena Pantić, Julia Schüler, Michael Lübbert

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization

    Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization 由 Zhou Jy, AW Norman, Michael Lübbert, E. D. Collins, MR Uskokovic, HP Koeffler

    出版 1989
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7

    Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7 由 Ingrid Furlan, Christiane Batz, Christian Flotho, Brigitte Mohr, Michael Lübbert, Meinolf Suttorp, Charlotte M. Niemeyer

    出版 2009
    获取全文
    Carta
    加到收藏夹
    Saved in:
  19. 19
    Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria

    Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria 由 Saskia Schmidt, Bettina Linnartz‐Gerlach, S. Mendritzki, Teresa Sczepan, Michael Lübbert, Christine C. Stichel, Hermann Lübbert

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes

    Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes 由 Stefanie Hauswald, Jesús Duque‐Afonso, Michaela Wagner, Florian M. Schertl, Michael Lübbert, Christian Peschel, Ulrich Keller, Thomas Licht

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: